The treatment and management of Marfan is tailored to the specific symptoms of each patient. Some patients find that the syndrome has little impact on their overall lifestyle; others have found their lives centered on the disorder.
About 90% of Marfan patients will develop cardiac complications.
Between 50 and 80% of Marfan patients have dislocated lenses.
Marfan syndrome affects males and females equally, and appears to be distributed equally among all races and ethnic groups.
Marfan syndrome causes an increase in the length of the patient's bones, with decreased support from the ligaments that hold the bones together.
Smoking is particularly harmful for Marfan patients because it increases their risk of emphysema.
While there is no cure for Marfan Syndrome (because it is a genetic disorder), there are ranges of treatment options can decrease (and even sometimes prevent) complications.
In patients with Marfan, it is the abnormal mitral valve that is most likely to become infected.
Although pectus carinatum does not cause breathing difficulties, it can cause embarassment about appearance.
While there is no cure for Marfan Syndrome (because it is a genetic disorder), there are ranges of treatment options can decrease (and even sometimes prevent) complications.
Gene therapy is being explored as a potential treatment for Marfan syndrome, as it has the potential to correct the underlying genetic mutation that causes the condition. However, further research is needed to determine its safety and efficacy before it can become a standard treatment option for Marfan syndrome.
Yes. A person with Marfan syndrome should have no problem flying in a commercial aircraft. Flights in an unpressurized aircraft are not recommended though, because the changes in altitude can cause a collapsed lung (pneumothorax), a particular risk for people with Marfan syndrome.
Marfan syndrome is found in 1 in every 5,000 - 10,000 births. If one of your parents has Marfan syndrome, you have a 50% chance of having Marfan syndrome.